vs
ALTISOURCE PORTFOLIO SOLUTIONS S.A.（ASPS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是ALTISOURCE PORTFOLIO SOLUTIONS S.A.的1.6倍（$69.8M vs $42.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -16.8%，领先400.9%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 3.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 3.6%）
Altisource Portfolio Solutions S.A.是面向抵押贷款、房地产及消费金融领域的全球服务商，为贷款机构、服务商、投资者等市场参与者提供技术、数据与运营解决方案，优化资产管理、房产交易等业务流程，提升客户运营效率。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ASPS vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.6倍
$42.3M
营收增速更快
RIGL
高出18.0%
3.2%
净利率更高
RIGL
高出400.9%
-16.8%
两年增速更快
RIGL
近两年复合增速
3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $42.3M | $69.8M |
| 净利润 | $-7.1M | $268.1M |
| 毛利率 | 26.5% | 91.5% |
| 营业利润率 | -15.5% | 33.2% |
| 净利率 | -16.8% | 384.0% |
| 营收同比 | 3.2% | 21.2% |
| 净利润同比 | 18.2% | 1769.2% |
| 每股收益（稀释后） | $-1.02 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPSRIGL
| Q4 25 | $42.3M | $69.8M | ||
| Q3 25 | $41.9M | $69.5M | ||
| Q2 25 | $43.3M | $101.7M | ||
| Q1 25 | $43.4M | $53.3M | ||
| Q4 24 | $41.0M | $57.6M | ||
| Q3 24 | $40.5M | $55.3M | ||
| Q2 24 | $39.1M | $36.8M | ||
| Q1 24 | $39.5M | $29.5M |
净利润ASPSRIGL
| Q4 25 | $-7.1M | $268.1M | ||
| Q3 25 | $-2.3M | $27.9M | ||
| Q2 25 | $16.7M | $59.6M | ||
| Q1 25 | $-5.3M | $11.4M | ||
| Q4 24 | $-8.7M | $14.3M | ||
| Q3 24 | $-9.3M | $12.4M | ||
| Q2 24 | $-8.3M | $-1.0M | ||
| Q1 24 | $-9.2M | $-8.2M |
毛利率ASPSRIGL
| Q4 25 | 26.5% | 91.5% | ||
| Q3 25 | 27.1% | 93.2% | ||
| Q2 25 | 30.1% | 95.6% | ||
| Q1 25 | 30.7% | 91.7% | ||
| Q4 24 | 30.3% | 89.9% | ||
| Q3 24 | 29.8% | 85.5% | ||
| Q2 24 | 32.5% | 92.4% | ||
| Q1 24 | 31.2% | 93.1% |
营业利润率ASPSRIGL
| Q4 25 | -15.5% | 33.2% | ||
| Q3 25 | 1.2% | 40.9% | ||
| Q2 25 | 7.5% | 60.1% | ||
| Q1 25 | 7.5% | 23.9% | ||
| Q4 24 | 1.4% | 28.9% | ||
| Q3 24 | 2.7% | 25.4% | ||
| Q2 24 | 5.3% | 1.2% | ||
| Q1 24 | -1.4% | -23.6% |
净利率ASPSRIGL
| Q4 25 | -16.8% | 384.0% | ||
| Q3 25 | -5.5% | 40.2% | ||
| Q2 25 | 38.5% | 58.6% | ||
| Q1 25 | -12.1% | 21.5% | ||
| Q4 24 | -21.3% | 24.9% | ||
| Q3 24 | -23.0% | 22.5% | ||
| Q2 24 | -21.1% | -2.8% | ||
| Q1 24 | -23.2% | -27.9% |
每股收益（稀释后）ASPSRIGL
| Q4 25 | $-1.02 | $14.11 | ||
| Q3 25 | $-0.22 | $1.46 | ||
| Q2 25 | $1.48 | $3.28 | ||
| Q1 25 | $-0.09 | $0.63 | ||
| Q4 24 | $-4.72 | $0.82 | ||
| Q3 24 | $-2.61 | $0.70 | ||
| Q2 24 | $-2.33 | $-0.06 | ||
| Q1 24 | $-0.33 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.6M | $155.0M |
| 总债务越低越好 | $191.1M | $52.5M |
| 股东权益账面价值 | $-110.2M | $391.5M |
| 总资产 | $139.8M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ASPSRIGL
| Q4 25 | $26.6M | $155.0M | ||
| Q3 25 | $28.6M | $137.1M | ||
| Q2 25 | $30.0M | $108.4M | ||
| Q1 25 | $30.8M | $77.1M | ||
| Q4 24 | $29.8M | $77.3M | ||
| Q3 24 | $28.3M | $61.1M | ||
| Q2 24 | $29.7M | $49.1M | ||
| Q1 24 | $29.6M | $49.5M |
总债务ASPSRIGL
| Q4 25 | $191.1M | $52.5M | ||
| Q3 25 | $192.5M | $60.0M | ||
| Q2 25 | $193.9M | $60.0M | ||
| Q1 25 | $195.0M | $60.0M | ||
| Q4 24 | $230.5M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ASPSRIGL
| Q4 25 | $-110.2M | $391.5M | ||
| Q3 25 | $-104.2M | $117.6M | ||
| Q2 25 | $-102.7M | $81.9M | ||
| Q1 25 | $-119.8M | $18.6M | ||
| Q4 24 | $-157.4M | $3.3M | ||
| Q3 24 | $-149.4M | $-14.6M | ||
| Q2 24 | $-140.8M | $-29.9M | ||
| Q1 24 | $-133.3M | $-31.7M |
总资产ASPSRIGL
| Q4 25 | $139.8M | $513.6M | ||
| Q3 25 | $139.9M | $242.5M | ||
| Q2 25 | $142.9M | $206.7M | ||
| Q1 25 | $145.7M | $176.0M | ||
| Q4 24 | $143.6M | $164.0M | ||
| Q3 24 | $144.5M | $139.4M | ||
| Q2 24 | $146.6M | $128.4M | ||
| Q1 24 | $148.9M | $126.5M |
负债/权益比ASPSRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-505.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-525.0K | — |
| 自由现金流率自由现金流/营收 | -1.2% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-5.1M | — |
8季度趋势，按日历期对齐
经营现金流ASPSRIGL
| Q4 25 | $-505.0K | $22.0M | ||
| Q3 25 | $718.0K | $24.0M | ||
| Q2 25 | $-306.0K | $30.5M | ||
| Q1 25 | $-5.0M | $-893.0K | ||
| Q4 24 | $-1.4M | $14.5M | ||
| Q3 24 | $-1.6M | $21.7M | ||
| Q2 24 | $180.0K | $302.0K | ||
| Q1 24 | $-2.2M | $-5.0M |
自由现金流ASPSRIGL
| Q4 25 | $-525.0K | — | ||
| Q3 25 | $697.0K | — | ||
| Q2 25 | $-309.0K | — | ||
| Q1 25 | $-5.0M | — | ||
| Q4 24 | $-1.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ASPSRIGL
| Q4 25 | -1.2% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | -0.7% | — | ||
| Q1 25 | -11.5% | — | ||
| Q4 24 | -3.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ASPSRIGL
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率ASPSRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | -0.02× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPS
| Services | $39.9M | 94% |
| Revenue Relatedto Technology Platformsand Professional Services | $2.4M | 6% |
RIGL
暂无分部数据
